Treace Medical Concepts (TMCI) Inventory (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Inventory for 7 consecutive years, with $39.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory fell 6.73% year-over-year to $39.5 million; the trailing twelve-month figure through Jun 2026 stood at $39.5 million (down 6.73% YoY), and the FY2025 full-year result was $36.0 million, down 8.21% from the prior year.
• Inventory advanced to $39.5 million in Q2 2026 per TMCI's latest filing, from $36.4 million in the prior quarter.
• Across five years, Inventory topped out at $43.6 million in Q3 2024 and bottomed at $11.1 million in Q1 2022.
• Historically, Inventory has averaged $31.2 million across 5 years, with a median of $35.9 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Inventory jumped 102.65% in 2023, then fell 8.21% in 2025.
• Over 5 years, Inventory stood at $19.3 million in 2022, then jumped by 51.29% to $29.2 million in 2023, then jumped by 34.23% to $39.3 million in 2024, then fell by 8.21% to $36.0 million in 2025, then increased by 9.74% to $39.5 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $39.5 million, $36.4 million, and $36.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.